NCT07161037: Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
- State
- Under way
- Phase
- Phase 2
- People
- 26 taking part
- Started
- 19 Nov 2025
- Primary completion
- 22 Jul 2027
- Arms
- VX-407
- Results
- None posted
- 8 Sep 2025: Trial registered
- 19 Nov 2025: Trial started